I N P S C O N F E R E N C E N O V E M B E R 12 TH AND 13 TH, Overview

Transcription

1 I N P S C O N F E R E N C E N O V E M B E R 12 TH AND 13 TH, Overview These courses are designed to meet with continuing education needs of advanced practice nurses. There will be an intense review and update of new pharmacological agents. Discussion of drugs and treatment modalities relating to specific illnesses will be reviewed at length. Drug actions and Indications for use and contraindications and side effects will be presented. Explain basic pharmacological and pharmacokinetic principles as they relate to devising a proper therapeutic regimen. Utilize evidence based medicine to select an appropriate therapeutic treatment plan for a given patient condition. Determine appropriate use for pharmacologic agents. Credit These courses have been submitted to AANP for hours of pharmacology credit.

2 Thursday, November 12, 2015 Breakfast/Business Meeting 7:30-8:15 Conference Welcome 8:15 8:15 Governor Terry Branstad to sign Proclamation 8:30-9:45 Antibiotic Update: Smart Prescribers make Smart Choices 1. Utilize the most current evidence based guidelines to treat common bacterial infections. 2. Be able to discuss current patterns of antibiotic resistance. 3. Describe newly developed antibiotics and their advantages for use in treatment of common infections. Sherry Buske, INPS President Kathy Morris, DNP, APRN, FNP-C Des Moines Main Conference Room Des Moines Main Conference Room Amelie Hollier DNP, FNP-BC 9:45 10:30 Break exhibits Exhibitors 10:30-11:30 Title: Dermatologic Drugs: Everything you re itching to know! 1. Develop strategies for use of oral and topical steroids to treat common inflammatory skin conditions. 2. Develop strategies to prescribe dermatologic medications used to manage common fungal infections. 3. Develop strategies for use of oral and topical medications to treat bacterial skin infections. 11:30-12:15 Diabetes I Oral Medications in Diabetes Amelie Hollier DNP, FNP-BC Dixie Harms, DNP 1. Describe pathophysiology of diabetes 2. Discuss use of oral diabetes medications 3. Discuss use of injectable medications for treatment of uncontrolled diabetes 4. Review case studies for patients with diabetes

3 12:30-1:15 Lunch/Diabetes II Injectable Medications in Diabetes Dixie Harms, DNP 1. Describe pathophysiology of diabetes 2. Discuss use of oral diabetes medications 3. Discuss use of injectable medications for treatment of uncontrolled diabetes 4. Review case studies for patients with diabetes 1:15-1:30 Break exhibits 1:30-2:30 AANP IBD Lecture: Inflammatory Bowel Disease: Advances in Immunopathogenesis and Treatment Julia Pallentino MSN, JD, FNP-BC, FAANP Discuss the pathophysiology, genetic components, and immunopathogenesis of IBD and how this translates to individualizing treatment strategies Understand current and novel therapies, their mechanisms of action, side effects, and monitoring requirements Evaluate patient disease activity, quality of life, and patient education resources on treatment therapies to support optimal understanding and adherence 3:00-3:15 Break/exhibits 3:15-4:30 A Review of COPD treatments for the Primary Care Provider Dr. Geoff Wall 1-Describe the etiology, epidemiology, pharmacological needs and costs associated with COPD 2-Review and apply the GOLD guidelines including the pharmacological management of COPD 3-Detail the ACCP guidelines for prevention of exacerbations of COPD 5:00-6:00 5:00 Wine and Beer Reception Celebration NP in Iowa Scholarship Award Ceremony

4 Friday November 13, 2015 Breakfast/Vendors 7:00-7:30 7:15-7:45 Annual INPS Member Meeting 7:45-8:00 Welcome Back! 8:00-9:00 Legal Issues and Prescribing: Preventing Malpractice and Other awful experiences : Julia Pallentino MSN, JD, FNP-BC, Identify the source of laws regulating prescribing practice Name 3 most commons prescribing practices that result in legal liability Describe safe prescription on practices regarding controlled substances Describe the consequences of negligent prescribing 9:00-10:00 Common Medications in OB/GYN : 1. Review indications and safety information of medications commonly used during pregnancy 2. Review indications and safety information of medications commonly used during labor 3. Review indications and safety information commonly used in gynecology Amy Bingaman, MD 10:00-10:30 Break/Exhibitors /snacks

5 10:30-11:30 Travel Medicine Ensuring Patient Safety for International Travel: Vaccines, Pharmaceuticals and More At the conclusion of the program, participants will be able to identify 6 major vaccine-preventable, or treatable travel-related illnesses Joy Elwell, DNP Major travel-related diseases: Hepatitis A Hepatitis B Typhoid Malaria Yellow fever Ebola 11:30-12:30 Pediatric Pharmacology/ Update in Primary Care : 1. Describe select pediatric pharmacokinetic (PK) and pharmacodynamics (PD) principles. 2. Identify the importance of appropriate drug dosing in the pediatric population. 3. Recognize newer recommendations and warnings on the use of established medications and select updated recommendations for therapies in the pediatric population. 12:45-1:45 Lunch- Depression /Anxiety: Latest in Treatment Recommendations : 1. Explain the mechanism of action of commonly prescribed psychotropic medications used in the treatment of mood disorders including depression and anxiety. Margaret Fitzgerald - DNP, FNP- BC, NP-C, FAANP, CSP, FAAN, DOC Margaret Fitzgerald - DNP, FNP- BC, NP-C, FAANP, CSP, FAAN, DOC 2. Describe factors influencing the choice of a psychotropic medication for the treatment of common mood disorders. 3. Identify common adverse effects and therapeutic advantages of the abovementioned medications 1:45-2:00 Break Vendors

6 2:00-3:00 AFIB Stroke Prevention in Patients with Atrial Fibrillation : Review the epidemiology, pathophysiology, and risk factors for stroke in atrial fibrillation Use validated risk assessment tools to assess and stratify patients with atrial fibrillation for the risk of stroke Describe approved anticoagulants, including their mechanism of action, safety, efficacy, indications, and contraindications Identify measures to assess bleeding risk in patients treated with anticoagulants Implement appropriate primary and secondary pharmacologic and nonpharmacologic interventions for stroke prevention tailored to risk stratification and patient characteristics, with knowledge of clinical guidelines, recommendations, and considerations of special populations 3:15-4:30 Medical Cannabis- High Expectations 1. Define medical cannabis using the American Association of Colleges of Pharmacy standard definition. 2. Cite claimed and verified medical uses for cannabinoids 3. Discuss administration of cannabinoids 4. Formulate policy opinions on medical cannabinoids Mary Ellen Roberts DNP, RN, APNC, FAAN, FAANP Dr. Ally Dering- Anderson 4:30 Close